These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1848268)
1. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW J Infect; 1991 Jan; 22(1):45-52. PubMed ID: 1848268 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit. Longman LP; Martin MV J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301 [TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. Van Cutsem J Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Van t Wout JW; Mattie H; van Furth R Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B]. van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200 [TBL] [Abstract][Full Text] [Related]
7. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349 [TBL] [Abstract][Full Text] [Related]
8. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. de Gans J; Portegies P; Tiessens G; Eeftinck Schattenkerk JK; van Boxtel CJ; van Ketel RJ; Stam J AIDS; 1992 Feb; 6(2):185-90. PubMed ID: 1313682 [TBL] [Abstract][Full Text] [Related]
9. Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. van 't Wout JW; Raven EJ; van der Meer JW J Infect; 1990 Mar; 20(2):147-50. PubMed ID: 2156938 [TBL] [Abstract][Full Text] [Related]
10. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616 [TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies. Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Denning DW; Hall L; Jackson M; Hollis S Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923 [TBL] [Abstract][Full Text] [Related]
13. Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole. Sachs MK; Paluzzi RG; Moore JH; Fraimow HS; Ost D Lancet; 1990 Jun; 335(8703):1475. PubMed ID: 1972255 [No Abstract] [Full Text] [Related]
14. False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft. Nussaume O; Elzaabi M; Icard P; Branger C; Bouttier S; Andreassian B Ann Vasc Surg; 1990 Jul; 4(4):388-92. PubMed ID: 2163668 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Polak A Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362 [TBL] [Abstract][Full Text] [Related]
17. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism. Schaffner A; Böhler A Mycoses; 1993; 36(11-12):421-4. PubMed ID: 7935575 [TBL] [Abstract][Full Text] [Related]
18. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. Warn PA; Morrissey G; Morrissey J; Denning DW J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746 [TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Mills W; Chopra R; Linch DC; Goldstone AH Br J Haematol; 1994 Apr; 86(4):754-60. PubMed ID: 7918068 [TBL] [Abstract][Full Text] [Related]
20. Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia. Kaptan K; Ural AU; Cetin T; Avcu F; Beyan C; Yalçin A J Infect Chemother; 2003 Mar; 9(1):40-5. PubMed ID: 12673406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]